Related Experiment Videos
Psychiatric illness and human renal transplantation
The Journal of Clinical Psychiatry
|May 1, 1978
Summary
Psychiatric issues are common in renal transplant patients. Corticosteroid and methyldopa medications were identified as key causes of depression in these individuals.
Area of Science:
- Nephrology and Psychiatry
- Transplantation Medicine
- Psychopharmacology
Background:
- Renal transplant recipients often experience psychological distress.
- Understanding the etiology of psychiatric disorders in this population is crucial for effective management.
Observation:
- Twenty renal transplant recipients were assessed over 18 months.
- A range of psychiatric conditions were identified.
- Eight patients were diagnosed with secondary depression.
Findings:
- Corticosteroid therapy was linked to depressive syndromes.
- Methyldopa treatment also emerged as a significant factor in depression.
- These medications are implicated as etiologic agents.
Implications:
- The study highlights the need for careful psychiatric monitoring post-transplant.
- It suggests specific pharmacological agents contributing to depression.
- A structured management approach for depressed renal transplant patients is proposed.